首页> 外文期刊>Medical care >Evaluation of a Medicaid Lock-in Program Increased Use of Opioid Use Disorder Treatment but No Impact on Opioid Overdose Risk
【24h】

Evaluation of a Medicaid Lock-in Program Increased Use of Opioid Use Disorder Treatment but No Impact on Opioid Overdose Risk

机译:评估医疗补助锁定程序的增加使用适应性使用障碍治疗,但对阿片类药物过量风险没有影响

获取原文
获取原文并翻译 | 示例
           

摘要

Background: "Lock-in" programs (LIPs) identify beneficiaries demonstrating potential overutilization of opioids, and other controlled substances, and restrict their access to these medications. LIPs are expanding to address the opioid crisis and could be an effective tool for connecting people to opioid use disorder treatment. We examined the immediate and sustained effects of a Medicaid LIP on overdose risk and use of medication-assisted treatment (MAT) for opioid use disorder. Methods: We analyzed North Carolina Medicaid claims from July 2009 through June 2013. We estimated daily risk differences and ratios of MAT use and overdose during lock-in and following release from the program, compared with periods before program enrollment. Results: The daily probability of MAT use during lock-in and following release was greater, when compared with a period just before LIP enrollment [ daily risk ratios: 1.50, 95% confidence interval (CI): 1.18-1.91; 2.27, 95% CI: 1.07-4.80; respectively]. Beneficiaries' average overdose risk while enrolled in the program and following release was similar to their risk just before enrollment (daily risk ratios: 1.01, 95% CI: 0.79-1.28; 1.12, 95% CI: 0.82-1.54; respectively). Discussion: North Carolina's Medicaid LIP was associated with increased use of MAT during enrollment, and this increase was sustained in the year following release from the program. However, we did not observe parallel reductions in overdose risk during lockin and following release. Identifying facilitators of MAT access and use among this population, as well as potential barriers to overdose reduction are important next steps to ensuring effective LIP design.
机译:背景:“锁定”程序(嘴唇)识别证明阿片类药物和其他受控物质的潜在过度抵制的受益人,并限制他们对这些药物的途径。嘴唇正在扩大以解决阿片类药物危机,并且可能是将人与阿片类药物使用障碍治疗的有效工具。我们检查了医疗补助唇对Overdose风险和使用药物辅助治疗(MAT)的即时和持续影响,用于阿片类药物使用障碍。方法:从2009年7月至2013年6月分析了北卡罗来纳医疗补助声明。我们在计划入学前的时期估计锁定和后续释放期间,估计日常风险差异和垫子使用和过量的比例。结果:与唇部入学前的一段时间进行比较[日常风险比:1.50,95%置信区间(CI):1.18-1.91; 2.27,95%CI:1.07-4.80;分别]。受益人在计划中注册的平均过量风险以及以下发布类似于入学前的风险(每日风险比率:1.01,95%CI:0.79-1.28; 1.12,95%CI:0.82-1.54;讨论:北卡罗来纳州的医疗补助唇部与入学期间垫子的使用增加有关,并且在该计划发布后的一年内持续这种增加。但是,我们在锁定过程中没有观察到过量的过量风险的平行减少。识别垫子的促进者和这种人口中的使用,以及过量减少的潜在障碍是确保有效唇部设计的重要下一步。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号